~~<i id='D64A702346'><strike id='D64A702346'><tt id='D64A702346'><pre id='D64A702346'></pre></tt></strike></i>~~

Home» leisure time» fashion

fashion

author：leisure time 2025-09-29 11:14:16 Page View：396

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New documents shed light on MD Anderson Cancer Institute feud
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies